Tearsheet

Intuitive Surgical (ISRG)

Market Price (10/15/2025): $437.37 | Market Cap: $156.8 Bil
Sector: Health Care | Industry: Health Care Equipment

Intuitive Surgical (ISRG)

Market Price (10/15/2025): $437.37
Market Cap: $156.8 Bil
Sector: Health Care
Industry: Health Care Equipment

Investment Highlights

0	Attractive operating margins Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 29%	Weak multi-year price returns 2Y Excs Rtn is -5.9%	Expensive valuation multiples P/EBITPrice/EBIT or Price/(Operating Income) ratio is 59x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 55x, P/EPrice/Earnings or Price/(Net Income) is 60x
1	Attractive cash flow generation CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 31%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 22%, CFO LTM is 2.8 Bil		Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -2.7%
2	Low stock price volatility Vol 12M is 34%

0	Attractive operating margins Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 29%
1	Attractive cash flow generation CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 31%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 22%, CFO LTM is 2.8 Bil
2	Low stock price volatility Vol 12M is 34%
3	Weak multi-year price returns 2Y Excs Rtn is -5.9%
4	Expensive valuation multiples P/EBITPrice/EBIT or Price/(Operating Income) ratio is 59x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 55x, P/EPrice/Earnings or Price/(Net Income) is 60x
5	Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -2.7%

Market Valuation & Key Metrics

Valuation
Key Metrics

	10/15/25	2024	2023	2022	2021
Share Price CYE	$437.37	$521.96	$337.36	$265.35	$359.30
Market Cap CYE ($ Bil)	156.8	186.0	118.7	93.2	128.5
Total Debt ($ Bil)	0.0	0.0	0.0	0.0	0.1
Total Cash ($ Bil)	5.3	4.0	5.2	4.1	4.2
Enterprise Value ($ Bil)	151.5	186.0	118.7	93.2	128.6
Valuation Ratios
P/S TTM	17.1	22.2	16.6	15.2	22.4
P/EBIT TTM	59.5	78.9	67.1	59.9	70.3
P/E TTM	60.1	79.8	65.9	71.4	75.1
Sector Ratios
P/S TTM (Sector)	4.0	3.5	4.1	4.6	7.4
P/EBIT TTM (Sector)	-1.7	-1.3	-1.4	-1.3	-2.7
P/E TTM (Sector)	-2.0	-1.6	-1.5	-1.3	-2.8

	10/15/25	2024	2023
Share Price CYE	$437.37	$521.96	$337.36
Market Cap CYE ($ Bil)	156.8	186.0	118.7
Total Debt ($ Bil)	0.0	0.0	0.0
Total Cash ($ Bil)	5.3	4.0	5.2
Enterprise Value ($ Bil)	151.5	186.0	118.7
Valuation Ratios
P/S TTM	17.1	22.2	16.6
P/EBIT TTM	59.5	78.9	67.1
P/E TTM	60.1	79.8	65.9
Sector Ratios
P/S TTM (Sector)	4.0	3.5	4.1
P/EBIT TTM (Sector)	-1.7	-1.3	-1.4
P/E TTM (Sector)	-2.0	-1.6	-1.5

	ISRG	S&P 500
REVENUE GROWTH	VERY GOOD
Rev LTM ($ Bil)	9.1
Rev Chg Q	21.4%	6.1%
Rev Chg LTM	20.8%	5.2%
Rev Chg 3Y Avg	15.4%	5.3%
PROFITABILITY	VERY GOOD
Op Inc LTM ($ Bil)	2.6
Op Mgn LTM	28.8%	18.6%
CFO LTM ($ Bil)	2.8
CFO/Rev LTM	30.9%	20.3%
Net Inc LTM ($ Bil)	2.6
Net Inc Mgn	28.5%	12.7%
VALUATION	VERY HIGH
P/S	17.1	3.2
P/CFO	55.5	15.7
P/FCF	78.6	20.6
P/E	60.1	23.6
STABILITY	VERY GOOD
Debt/Equity	0.00	0.21
Cash/Assets	0.26	0.07

ISRG Stock

Return (1M):

Factor Drivers of Stock Movement

The -14.8% change in ISRG stock from 7/15/2025 to 10/14/2025 was primarily driven by a -18.9% change in the company's P/E Multiple.

	7152025	10142025	Change
Stock Price ($)	512.23	436.39	-14.81%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	8714.90	9145.00	4.94%
Net Income Margin (%)	28.41%	28.51%	0.36%
P/E Multiple	73.96	60.00	-18.88%
Shares Outstanding (Mil)	357.50	358.50	-0.28%
Cumulative Contribution			-14.81%

LTM = Last Twelve Months as of date shown

The -10.6% change in ISRG stock from 4/15/2025 to 10/14/2025 was primarily driven by a -19.9% change in the company's P/E Multiple.

	4152025	10142025	Change
Stock Price ($)	488.27	436.39	-10.63%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	8352.10	9145.00	9.49%
Net Income Margin (%)	27.81%	28.51%	2.54%
P/E Multiple	74.92	60.00	-19.92%
Shares Outstanding (Mil)	356.40	358.50	-0.59%
Cumulative Contribution			-10.63%

LTM = Last Twelve Months as of date shown

The -10.5% change in ISRG stock from 10/14/2024 to 10/14/2025 was primarily driven by a -27.4% change in the company's P/E Multiple.

	10142024	10142025	Change
Stock Price ($)	487.61	436.39	-10.50%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	7572.50	9145.00	20.77%
Net Income Margin (%)	27.65%	28.51%	3.13%
P/E Multiple	82.68	60.00	-27.43%
Shares Outstanding (Mil)	355.00	358.50	-0.99%
Cumulative Contribution			-10.51%

LTM = Last Twelve Months as of date shown

The 138.4% change in ISRG stock from 10/15/2022 to 10/14/2025 was primarily driven by a 53.3% change in the company's Total Revenues ($ Mil).

	10152022	10142025	Change
Stock Price ($)	183.06	436.39	138.39%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	5963.80	9145.00	53.34%
Net Income Margin (%)	24.05%	28.51%	18.54%
P/E Multiple	45.70	60.00	31.29%
Shares Outstanding (Mil)	358.10	358.50	-0.11%
Cumulative Contribution			138.39%

LTM = Last Twelve Months as of date shown

Price Returns Compared

	2020	2021	2022	2023	2024	2025	Total [1]
Returns
ISRG Return	38%	32%	-26%	27%	55%	-16%	118%
Peers Return	3%	12%	-12%	12%	14%	4%	34%
S&P 500 Return	16%	27%	-19%	24%	23%	13%	103%
Monthly Win Rates [3]
ISRG Win Rate	50%	58%	42%	50%	67%	44%
Peers Win Rate	52%	55%	48%	55%	62%	58%
S&P 500 Win Rate	58%	75%	42%	67%	75%	67%
Max Drawdowns [4]
ISRG Max Drawdown	-38%	-16%	-49%	-15%	-5%	-18%
Peers Max Drawdown	-35%	-9%	-26%	-8%	-8%	-8%
S&P 500 Max Drawdown	-31%	-1%	-25%	-1%	-2%	-15%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: BSX, SYK, MDT, BDX, EW. See ISRG Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/14/2025 (YTD)

Downturns Compared

Unique Key	Event	ISRG	S&P 500
2022 Inflation Shock	2022 Inflation Shock
2022 Inflation Shock% Loss	% Loss	-49.9%	-25.4%
2022 Inflation Shock% Gain to Breakeven	% Gain to Breakeven	99.6%	34.1%
2022 Inflation ShockTime to Breakeven	Time to Breakeven	461 days	464 days
2020 Covid Pandemic	2020 Covid Pandemic
2020 Covid Pandemic% Loss	% Loss	-40.5%	-33.9%
2020 Covid Pandemic% Gain to Breakeven	% Gain to Breakeven	68.1%	51.3%
2020 Covid PandemicTime to Breakeven	Time to Breakeven	116 days	148 days
2018 Correction	2018 Correction
2018 Correction% Loss	% Loss	-24.3%	-19.8%
2018 Correction% Gain to Breakeven	% Gain to Breakeven	32.2%	24.7%
2018 CorrectionTime to Breakeven	Time to Breakeven	87 days	120 days
2008 Global Financial Crisis	2008 Global Financial Crisis
2008 Global Financial Crisis% Loss	% Loss	-75.9%	-56.8%
2008 Global Financial Crisis% Gain to Breakeven	% Gain to Breakeven	314.7%	131.3%
2008 Global Financial CrisisTime to Breakeven	Time to Breakeven	364 days	1480 days

How Low Can It Go?

Intuitive Surgical's stock fell -49.9% during the 2022 Inflation Shock from a high on 11/8/2021. A -49.9% loss requires a 99.6% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Intuitive Surgical (ISRG)

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Interactive Breakdown

Intuitive Surgical Interactive Breakdown Analysis

Better Bets than Intuitive Surgical (ISRG)

	ISRG	Better Performance than ISRG
Metric	Value	Industry (Health Care Equipment)
Rev Chg LTM	20.8%	BSX (21.4%), PODD (26.0%), GKOS (26.7%), TMDX (64.4%), INSP (22.0%)
Rev Chg 3Y Avg	15.4%	DXCM (17.3%), PODD (26.1%), PEN (16.7%), GMED (44.7%), TMDX (139.5%)
Op Mgn LTM	28.8%	IDXX (31.1%), RMD (32.8%), UTMD (33.3%)
CFO/Rev LTM	30.9%	RMD (34.0%), UTMD (36.4%)
FCF/Rev LTM	21.8%	RMD (32.1%), HOLX (24.1%), LMAT (22.3%), UTMD (35.5%)
Total Yield	1.7%	ABT (7.8%), BSX (1.8%), SYK (2.9%), MDT (6.7%), BDX (5.1%)

	ISRG	Better Performance than ISRG
Metric	Value	Sector (Health Care)
Rev Chg LTM	20.8%	LLY (36.8%), BSX (21.4%), CI (24.6%), INSM (21.2%), NTRA (44.4%)
Rev Chg 3Y Avg	15.4%	LLY (23.4%), ALNY (40.8%), INSM (21.6%), DXCM (17.3%), NTRA (39.7%)
Op Mgn LTM	28.8%	LLY (43.0%), MRK (31.2%), GILD (37.4%), ZTS (37.5%), IDXX (31.1%)
CFO/Rev LTM	30.9%	ABBV (33.1%), AMGN (34.4%), GILD (34.2%), VRTX (33.7%), ZTS (31.2%)
FCF/Rev LTM	21.8%	ABBV (31.3%), MRK (23.1%), AMGN (30.4%), GILD (32.5%), VRTX (30.6%)
Total Yield	1.7%	LLY (2.6%), JNJ (7.6%), ABBV (3.8%), UNH (8.9%), ABT (7.8%)

	ISRG	Better Performance than ISRG
Metric	Value	All Other Sectors
Rev Chg LTM	20.8%	NVDA (71.6%), AVGO (28.0%), PLTR (38.8%), AMD (27.2%), MU (48.9%)
Rev Chg 3Y Avg	15.4%	NVDA (92.0%), AVGO (24.0%), PLTR (25.7%), MU (20.3%), APP (23.7%)
Op Mgn LTM	28.8%	NVDA (58.1%), MSFT (45.6%), AAPL (31.9%), GOOGL (32.7%), META (42.9%)
CFO/Rev LTM	30.9%	NVDA (46.6%), MSFT (48.3%), GOOGL (36.0%), META (56.4%), AVGO (42.4%)
FCF/Rev LTM	21.8%	NVDA (43.6%), MSFT (25.4%), AAPL (23.5%), META (30.7%), AVGO (41.6%)
Total Yield	1.7%	NVDA (2.0%), MSFT (3.3%), AAPL (3.1%), GOOGL (4.2%), AMZN (3.1%)

Latest Trefis Analyses

	Title	Topic	Date
0	DASHBOARDS
1	Intuitive Surgical Earnings Notes
2	High Margins, Lower Price: Is ISRG a Buy?	Actionable
3	PODD, UFPT Look Smarter Buy Than Intuitive Surgical Stock	Actionable
4	ISRG At Price Support Zone, Right Time To Buy?	Actionable
5	ISRG Slides 5.9% In A Single Day: Where Does It Rank Among Competitors?
6	Intuitive Surgical vs Eli Lilly: Which Is A Better Investment?	Counter-Intuitive Comparisons
7	Better Bet Than ISRG Stock: Pay Less Than Intuitive Surgical To Get More From LLY, PODD
8	Better Bet Than ISRG Stock: Pay Less Than Intuitive Surgical To Get More From PODD, GMED
9	Better Bet Than ISRG Stock: Pay Less Than Intuitive Surgical To Get More From GMED, PODD, UFPT	Actionable
10	ISRG Dip Buy Analysis
11	ARTICLES
12	ISRG Near Crucial Support Level – Buy Signal Ahead		October 2nd, 2025
13	Better Bet Than Intuitive Surgical Stock: Pay Less To Get More From PODD		September 30th, 2025
14	Better Bet Than Intuitive Surgical Stock: Pay Less To Get More From PODD		September 9th, 2025
15	Buy or Sell Intuitive Surgical Stock?		September 4th, 2025
16	ISRG Dips 5.9% In One Day: Does It Lead the Pack?		September 4th, 2025

	Title
0	DASHBOARDS
1	ISRG Near Crucial Support Level – Buy Signal Ahead
2	Better Bet Than Intuitive Surgical Stock: Pay Less To Get More From PODD
3	Better Bet Than Intuitive Surgical Stock: Pay Less To Get More From PODD
4	Buy or Sell Intuitive Surgical Stock?
5	ISRG Dips 5.9% In One Day: Does It Lead the Pack?
6	ARTICLES
7	Intuitive Surgical Earnings Notes
8	High Margins, Lower Price: Is ISRG a Buy?
9	PODD, UFPT Look Smarter Buy Than Intuitive Surgical Stock
10	ISRG At Price Support Zone, Right Time To Buy?
11	ISRG Slides 5.9% In A Single Day: Where Does It Rank Among Competitors?
12	Intuitive Surgical vs Eli Lilly: Which Is A Better Investment?
13	Better Bet Than ISRG Stock: Pay Less Than Intuitive Surgical To Get More From LLY, PODD
14	Better Bet Than ISRG Stock: Pay Less Than Intuitive Surgical To Get More From PODD, GMED
15	Better Bet Than ISRG Stock: Pay Less Than Intuitive Surgical To Get More From GMED, PODD, UFPT
16	ISRG Dip Buy Analysis

Trade Ideas

Select past trade ideas related to ISRG and Health Care Equipment.

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
ADMA_9302025_Dip_Buyer_ValueBuy	09302025	ADMA	ADMA Biologics	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	2.0%	2.0%	-4.6%
REGN_9302025_Dip_Buyer_ValueBuy	09302025	REGN	Regeneron Pharmaceuticals	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	1.8%	1.8%	-0.8%
HAE_9262025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	09262025	HAE	Haemonetics	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	3.3%	3.3%	-0.1%
WAT_9192025_Monopoly_xInd_xCD_Getting_Cheaper	09192025	WAT	Waters	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	10.7%	10.7%	-4.3%
ISRG_9052025_Monopoly_xInd_xCD_Getting_Cheaper	09052025	ISRG	Intuitive Surgical	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	-6.5%	-6.5%	-8.0%
ISRG_10312022_Monopoly_xInd_xCD_Getting_Cheaper	10312022	ISRG	Intuitive Surgical	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	22.9%	6.4%	-8.8%
ISRG_4302022_Monopoly_xInd_xCD_Getting_Cheaper	04302022	ISRG	Intuitive Surgical	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	2.0%	25.9%	-23.5%
ISRG_3312020_Monopoly_xInd_xCD_Getting_Cheaper	03312020	ISRG	Intuitive Surgical	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	39.9%	49.2%	-7.5%
ISRG_8312019_Monopoly_xInd_xCD_Getting_Cheaper	08312019	ISRG	Intuitive Surgical	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	4.4%	42.2%	-28.1%

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
ADMA_9302025_Dip_Buyer_ValueBuy	09302025	ADMA	ADMA Biologics	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	2.0%	2.0%	-4.6%
REGN_9302025_Dip_Buyer_ValueBuy	09302025	REGN	Regeneron Pharmaceuticals	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	1.8%	1.8%	-0.8%
HAE_9262025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	09262025	HAE	Haemonetics	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	3.3%	3.3%	-0.1%
WAT_9192025_Monopoly_xInd_xCD_Getting_Cheaper	09192025	WAT	Waters	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	10.7%	10.7%	-4.3%
ISRG_9052025_Monopoly_xInd_xCD_Getting_Cheaper	09052025	ISRG	Intuitive Surgical	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	-6.5%	-6.5%	-8.0%
ISRG_10312022_Monopoly_xInd_xCD_Getting_Cheaper	10312022	ISRG	Intuitive Surgical	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	22.9%	6.4%	-8.8%
ISRG_4302022_Monopoly_xInd_xCD_Getting_Cheaper	04302022	ISRG	Intuitive Surgical	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	2.0%	25.9%	-23.5%
ISRG_3312020_Monopoly_xInd_xCD_Getting_Cheaper	03312020	ISRG	Intuitive Surgical	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	39.9%	49.2%	-7.5%
ISRG_8312019_Monopoly_xInd_xCD_Getting_Cheaper	08312019	ISRG	Intuitive Surgical	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	4.4%	42.2%	-28.1%

See Trefis Trade Ideas for more.

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	SSII	SS Innovations International	34.5%	15.2%
2	NVTS	Navitas Semiconductor	26.1%	252.1%
3	LAC	Lithium Americas	19.2%	238.4%
4	INDI	Indie Semiconductor	18.6%	37.3%
5	OUST	Ouster	16.4%	195.9%
6	FLNC	Fluence Energy	16.1%	16.2%
7	DBRG	DigitalBridge	15.7%	19.9%
8	CRNC	Cerence	15.6%	66.5%
9	STOK	Stoke Therapeutics	15.2%	216.8%
10	ORLA	Orla Mining	14.3%	137.0%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	ALAB	Astera Labs	-19.0%	22.0%
2	CRDO	Credo Technology	-13.4%	93.1%
3	XNCR	Xencor	-11.0%	-45.9%
4	BCRX	BioCryst Pharmaceuticals	-8.8%	-14.6%
5	SGML	Sigma Lithium	-8.5%	-43.5%
6	INOD	Innodata	-7.2%	91.9%
7	SRRK	Scholar Rock	-6.9%	-26.2%
8	MBX	MBX Biosciences	-6.8%	-26.6%
9	RYN	Rayonier	-6.6%	-4.3%
10	MNPR	Monopar Therapeutics	-6.6%	333.1%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	UAMY	United States Antimony	100.8%	887.0%
2	BITF	Bitfarms	69.7%	295.3%
3	NVTS	Navitas Semiconductor	61.6%	252.1%
4	ASPI	ASP Isotopes	58.0%	210.2%
5	UUUU	Energy Fuels	49.1%	411.3%
6	GLUE	Monte Rosa Therapeutics	43.8%	52.9%
7	SSII	SS Innovations International	34.1%	15.2%
8	METC	Ramaco Resources	34.0%	439.5%
9	MP	MP Materials	33.7%	532.4%
10	ORKA	Oruka Therapeutics	33.6%	41.7%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	BNT	Brookfield Wealth Solutions	-33.2%	18.5%
2	BN	Brookfield	-33.0%	18.9%
3	VG	Venture Global	-30.2%
4	ALAB	Astera Labs	-23.8%	22.0%
5	HELE	Helen Of Troy	-23.3%	-65.4%
6	CORT	Corcept Therapeutics	-20.2%	43.1%
7	USNA	Usana Health Sciences	-19.4%	-40.9%
8	SRRK	Scholar Rock	-19.2%	-26.2%
9	TASK	TaskUs	-18.8%	-18.1%
10	BBBY	Bed Bath & Beyond	-18.1%

1 Month Top Gainers

#	Ticker	Company	1M Rtn	YTD Rtn
1	WOLF	Wolfspeed	1000.7%	389.2%
2	QURE	uniQure	297.4%	233.9%
3	UAMY	United States Antimony	244.6%	887.0%
4	LAC	Lithium Americas	214.1%	238.4%
5	RGTI	Rigetti Computing	192.1%	267.8%
6	USAR	USA Rare Earth	173.3%	125889.9%
7	PLUG	Plug Power	158.0%	90.1%
8	FLNC	Fluence Energy	149.7%	16.2%
9	CLPT	ClearPoint Neuro	148.6%	69.2%
10	SES	SES AI	140.2%	44.7%

1 Month Top Losers

#	Ticker	Company	1M Rtn	YTD Rtn
1	ANGX	Angel Studios	-53.8%
2	REX	REX American Resources	-46.2%	57.7%
3	VG	Venture Global	-34.0%
4	LDI	loanDepot	-33.8%	46.6%
5	FLY	Firefly Aerospace	-31.4%
6	ALAB	Astera Labs	-30.2%	22.0%
7	FWRD	Forward Air	-29.4%	-34.3%
8	USNA	Usana Health Sciences	-29.1%	-40.9%
9	IDT	IDT	-28.9%	-0.4%
10	PGY	Pagaya Technologies	-28.8%	221.4%

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	SSII	SS Innovations International	34.5%	15.2%
2	NVTS	Navitas Semiconductor	26.1%	252.1%
3	LAC	Lithium Americas	19.2%	238.4%
4	INDI	Indie Semiconductor	18.6%	37.3%
5	OUST	Ouster	16.4%	195.9%
6	FLNC	Fluence Energy	16.1%	16.2%
7	DBRG	DigitalBridge	15.7%	19.9%
8	CRNC	Cerence	15.6%	66.5%
9	STOK	Stoke Therapeutics	15.2%	216.8%
10	ORLA	Orla Mining	14.3%	137.0%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	ALAB	Astera Labs	-19.0%	22.0%
2	CRDO	Credo Technology	-13.4%	93.1%
3	XNCR	Xencor	-11.0%	-45.9%
4	BCRX	BioCryst Pharmaceuticals	-8.8%	-14.6%
5	SGML	Sigma Lithium	-8.5%	-43.5%
6	INOD	Innodata	-7.2%	91.9%
7	SRRK	Scholar Rock	-6.9%	-26.2%
8	MBX	MBX Biosciences	-6.8%	-26.6%
9	RYN	Rayonier	-6.6%	-4.3%
10	MNPR	Monopar Therapeutics	-6.6%	333.1%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	UAMY	United States Antimony	100.8%	887.0%
2	BITF	Bitfarms	69.7%	295.3%
3	NVTS	Navitas Semiconductor	61.6%	252.1%
4	ASPI	ASP Isotopes	58.0%	210.2%
5	UUUU	Energy Fuels	49.1%	411.3%
6	GLUE	Monte Rosa Therapeutics	43.8%	52.9%
7	SSII	SS Innovations International	34.1%	15.2%
8	METC	Ramaco Resources	34.0%	439.5%
9	MP	MP Materials	33.7%	532.4%
10	ORKA	Oruka Therapeutics	33.6%	41.7%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	BNT	Brookfield Wealth Solutions	-33.2%	18.5%
2	BN	Brookfield	-33.0%	18.9%
3	VG	Venture Global	-30.2%
4	ALAB	Astera Labs	-23.8%	22.0%
5	HELE	Helen Of Troy	-23.3%	-65.4%
6	CORT	Corcept Therapeutics	-20.2%	43.1%
7	USNA	Usana Health Sciences	-19.4%	-40.9%
8	SRRK	Scholar Rock	-19.2%	-26.2%
9	TASK	TaskUs	-18.8%	-18.1%
10	BBBY	Bed Bath & Beyond	-18.1%

Peer Comparisons for Intuitive Surgical

Financials

	ISRG	BSX	SYK	MDT	BDX	EW	Median
Name	Intuitiv.	Boston S.	Stryker	Medtronic	Becton D.	Edwards .
Mkt Price	436.39	96.24	370.00	96.54	188.36	73.36	142.45
Mkt Cap	156.4	142.4	141.4	123.7	54.1	43.1	132.6
Rev LTM	9,145	18,494	23,818	34,200	21,386	5,685	19,940
Op Inc LTM	2,634	3,388	4,683	6,647	2,955	1,588	3,172
FCF LTM	1,994	3,234	4,024	5,303	2,550	578	2,892
FCF 3Y Avg	1,197	2,114	3,081	4,964	2,504	599	2,309
CFO LTM	2,826	4,285	4,766	7,146	3,254	795	3,770
CFO 3Y Avg	2,116	3,014	3,735	6,625	3,278	867	3,146

Growth & Margins

	ISRG	BSX	SYK	MDT	BDX	EW	Median
Name	Intuitiv.	Boston S.	Stryker	Medtronic	Becton D.	Edwards .
Rev Chg LTM	20.8%	21.4%	11.4%	5.0%	7.9%	9.1%	10.2%
Rev Chg 3Y Avg	15.4%	14.6%	10.6%	3.3%	4.1%	3.0%	7.3%
Rev Chg Q	21.4%	22.8%	11.1%	8.4%	10.4%	11.9%	11.5%
QoQ Delta Rev Chg LTM	4.9%	5.4%	2.6%	2.0%	2.5%	2.9%	2.8%
Op Mgn LTM	28.8%	18.3%	19.7%	19.4%	13.8%	27.9%	19.5%
Op Mgn 3Y Avg	26.3%	17.6%	19.3%	18.6%	13.3%	29.5%	18.9%
QoQ Delta Op Mgn LTM	0.6%	-0.2%	-0.1%	-0.1%	0.9%	0.2%	0.1%
CFO/Rev LTM	30.9%	23.2%	20.0%	20.9%	15.2%	14.0%	20.5%
CFO/Rev 3Y Avg	26.9%	18.8%	17.2%	20.2%	16.3%	17.2%	18.0%
FCF/Rev LTM	21.8%	17.5%	16.9%	15.5%	11.9%	10.2%	16.2%
FCF/Rev 3Y Avg	15.0%	13.1%	14.1%	15.1%	12.4%	11.9%	13.6%

Valuation

	ISRG	BSX	SYK	MDT	BDX	EW	Median
Name	Intuitiv.	Boston S.	Stryker	Medtronic	Becton D.	Edwards .
Mkt Cap	156.4	142.4	141.4	123.7	54.1	43.1	132.6
P/S	17.1	7.7	5.9	3.6	2.5	7.6	6.8
P/EBIT	59.4	42.8	30.2	19.3	21.6	25.7	27.9
P/E	60.0	56.9	48.5	26.6	34.1	10.4	41.3
P/CFO	55.4	33.2	29.7	17.3	16.6	54.2	31.5
Total Yield	1.7%	1.8%	2.9%	6.7%	5.1%	9.6%	4.0%
Dividend Yield	0.0%	0.0%	0.9%	2.9%	2.2%	0.0%	0.4%
FCF Yield 3Y Avg	0.8%	1.8%	2.3%	4.5%	4.1%	1.1%	2.0%
D/E	0.0	0.1	0.1	0.2	0.4	0.0	0.1
Net D/E	-0.0	0.1	0.1	0.2	0.3	-0.1	0.1

Returns

	ISRG	BSX	SYK	MDT	BDX	EW	Median
Name	Intuitiv.	Boston S.	Stryker	Medtronic	Becton D.	Edwards .
1M Rtn	-3.0%	-6.3%	-3.3%	3.4%	0.8%	-5.4%	-3.1%
3M Rtn	-14.8%	-7.0%	-5.1%	9.0%	6.2%	-4.5%	-4.8%
6M Rtn	-10.6%	2.1%	7.2%	19.1%	-5.7%	3.7%	2.9%
12M Rtn	-10.5%	9.9%	3.8%	10.8%	-19.9%	5.4%	4.6%
3Y Rtn	138.4%	140.7%	82.3%	30.7%	-11.7%	-11.0%	56.5%
1M Excs Rtn	0.1%	-4.1%	-2.1%	3.7%	1.0%	-4.0%	-1.0%
3M Excs Rtn	-21.0%	-12.8%	-11.2%	2.3%	0.2%	-9.7%	-10.5%
6M Excs Rtn	-33.9%	-20.8%	-17.8%	-6.4%	-30.3%	-17.9%	-19.4%
12M Excs Rtn	-24.8%	-3.3%	-9.3%	-2.7%	-33.3%	-7.5%	-8.4%
3Y Excs Rtn	48.7%	59.5%	0.2%	-53.2%	-93.5%	-95.5%	-26.5%

Comparison Analyses

	Title
0	Intuitive Surgical vs. Edwards Lifesciences: With Return Forecast Of 36%, Intuitive Surgical Is A Better Bet
1	Intuitive Surgical vs. Medtronic: With Return Forecast Of 36%, Intuitive Surgical Is A Better Bet
2	Intuitive Surgical vs. Boston Scientific: With Return Forecast Of 32%-36%, Both Seem Like Good Bets
3	Intuitive Surgical vs. Stryker: With Return Forecast Of 36%, Intuitive Surgical Is A Better Bet
4	Intuitive Surgical vs. Becton Dickinson: With Return Forecast Of 36%, Intuitive Surgical Is A Better Bet
5	Intuitive Surgical vs. MercadoLibre: With Return Forecast Of 42%, MercadoLibre Is A Better Bet
6	Intuitive Surgical vs. Analog Devices: With Return Forecast Of 35%, Intuitive Surgical Is A Better Bet
7	Intuitive Surgical vs. Advanced Micro Devices: With Return Forecast Of 62%, Advanced Micro Devices Is A Better Bet
8	Intuitive Surgical vs. PepsiCo: With Return Forecast Of 42%, Intuitive Surgical Is A Better Bet
9	Intuitive Surgical vs. Palantir Technologies: With Return Forecast Of 42%, Intuitive Surgical Is A Better Bet

Financials

Annual
Quarterly

$ Mil \| FY: 12/31	LTM	2024	2023	2022	2021	2020	2019
Period End	6/30/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Filing Date	7/23/2025	1/31/2025	1/31/2024	2/10/2023	2/3/2022	2/10/2021	2/7/2020
Key Financials
Total Revenue	9,145	8,352	7,124	6,222	5,710	4,358	4,478
EBITDA	3,171	2,811	2,189	1,943	2,131	1,326	1,578
Operating Income	2,634	2,349	1,767	1,577	1,821	1,050	1,374
Net Income	2,608	2,323	1,798	1,322	1,705	1,061	1,379
EPS	7.30	6.54	5.12	3.72	4.79	3.02	3.98
Growth Rates
Total Revenue Growth	20.8%	17.2%	14.5%	9.0%	31.0%	-2.7%	20.3%
EBITDA Growth	31.8%	28.4%	12.6%	-8.8%	60.7%	-15.9%	19.3%
Operating Income Growth	34.9%	32.9%	12.0%	-13.4%	73.5%	-23.6%	14.6%
Net Income Growth	24.5%	29.2%	36.0%	-22.4%	60.7%	-23.1%	22.3%
Margins
EBITDA Margin	34.7%	33.7%	30.7%	31.2%	37.3%	30.4%	35.2%
Operating Income Margin	28.8%	28.1%	24.8%	25.3%	31.9%	24.1%	30.7%
Net Income Margin	28.5%	27.8%	25.2%	21.3%	29.9%	24.3%	30.8%
Cash & Debt
Total Cash	5,326	4,013	5,223	4,118	4,231	5,172	3,222
Total Debt	0	0	0	0	87	0	0
Net Debt / (Cash)	-5,326	-4,013	-5,223	-4,118	-4,144	-5,172	-3,222
Cash Flows
Net Cash from Operations	2,826	2,415	1,814	1,491	2,089	1,485	1,598
Free Cash from Operations	1,994	1,304	750	958	1,750	1,143	1,173
Returns to Shareholders
Dividends	0	-0	-0	-0	-0	-0	-0
Share Repurchases	-0	-0	416	2,607	-0	134	270

$ Mil \| FY: 12/31	2025Q2	2025Q1	2024Q4	2024Q3	2024Q2	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3
Period End	6/30/2025	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Filing Date	7/23/2025	4/23/2025	1/31/2025	10/18/2024	7/19/2024	4/19/2024	1/31/2024	10/20/2023	7/24/2023	4/20/2023	2/10/2023	10/21/2022
Key Financials Quarterly
Total Revenue	2,440	2,253	2,414	2,038	2,010	1,891	1,928	1,744	1,756	1,696	1,655	1,557
Ebitda	899	719	860	694	679	579	573	574	560	480	479	489
Operating Income	743	578	735	577	567	469	450	466	463	388	372	399
Net Income	658	698	686	565	527	545	606	416	421	355	325	324
EPS	1.84	1.95	1.92	1.59	1.48	1.54	1.72	1.18	1.20	1.01	0.93	0.91
Key Financials TTM
Total Revenue TTM	9,145	8,715	8,352	7,867	7,572	7,318	7,124	6,851	6,664	6,431	6,222	6,118
Ebitda TTM	3,171	2,951	2,811	2,525	2,406	2,287	2,189	2,094	2,008	1,931	1,943	1,996
Operating Income TTM	2,634	2,458	2,349	2,064	1,953	1,849	1,767	1,689	1,622	1,557	1,577	1,655
Net Income TTM	2,608	2,476	2,323	2,243	2,094	1,988	1,798	1,517	1,425	1,312	1,322	1,378
Growth Rates Quarterly
Total Revenue Growth	21.4%	19.2%	25.2%	16.9%	14.5%	11.5%	16.5%	12.0%	15.4%	14.0%	6.7%	11.0%
EBITDA Growth	32.3%	24.2%	49.9%	20.7%	21.2%	20.5%	19.8%	17.5%	15.9%	-2.4%	-9.9%	-6.8%
Operating Income Growth	31.0%	23.2%	63.2%	23.9%	22.5%	21.1%	20.9%	16.8%	16.5%	-5.0%	-17.3%	-9.9%
Net Income Growth	25.0%	28.2%	13.1%	35.9%	25.2%	53.4%	86.6%	28.3%	36.7%	-2.8%	-14.6%	-14.8%
Margins Quarterly
EBITDA Margin	36.8%	31.9%	35.6%	34.0%	33.8%	30.6%	29.7%	32.9%	31.9%	28.3%	28.9%	31.4%
Operating Income Margin	30.5%	25.7%	30.4%	28.3%	28.2%	24.8%	23.3%	26.7%	26.4%	22.9%	22.5%	25.6%
Net Income Margin	27.0%	31.0%	28.4%	27.7%	26.2%	28.8%	31.4%	23.8%	24.0%	20.9%	19.6%	20.8%
Cash & Debt
Total Cash	5,326	4,511	4,013	4,232	4,757	4,800	5,223	6,476	5,799	4,692	4,118	4,319
Total Debt	0	0	0	0	0	0	0	0	0	0	0	0
Net Debt / (Cash)	-5,326	-4,511	-4,013	-4,232	-4,757	-4,800	-5,223	-6,476	-5,799	-4,692	-4,118	-4,319
Cash Flows Quarterly
FCF from Operations	715	582	823	706	620	265	228	548	666	371	438	383
Cash Flows TTM
FCF from Operations TTM	2,826	2,731	2,415	1,821	1,663	1,708	1,814	2,023	1,858	1,639	1,491	1,621
Returns to Shareholders Quarterly
Dividends	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-0	-0	-0	-0	-0	-0	66	-0	-0	350	1,001	1,000
Return on Invested Capital (ROIC) Quarterly
ROIC	48.3%	42.4%	44.5%	37.6%	42.2%	45.9%	53.9%	80.8%	69.6%	42.4%	37.1%	40.5%
Return on Invested Capital (ROIC) TTM
ROIC TTM	47.2%	40.1%	36.6%	37.5%	42.3%	43.6%	49.1%	76.5%	60.2%	40.9%	38.5%	43.4%

Segment Financials

Revenue by Segment

$ Mil	2024	2023	2022	2021	2020
Instruments and Accessories	4,277	3,518	3,100	2,456	2,408
Systems	1,680	1,680	1,693	1,179	1,346
Services	1,168	1,024	916	724	724
Total	7,124	6,222	5,710	4,358	4,478

Price Behavior

Behavior Stats
Betas Matrix

Price Behavior

Market Price	$436.39
Market Cap ($ Bil)	156.4
First Trading Date	06/16/2000
Distance from 52W High	-28.5%
	50 Days	200 Days
DMA Price	$456.99	$514.22
DMA Trend	down	down
Distance from DMA	-4.5%	-15.1%
	3M	1YR
Volatility	26.0%	33.9%
Downside Capture	102.56	122.26
Upside Capture	-20.33	94.26
Correlation (SPY)	28.3%	71.4%

ISRG Betas & Captures as of 9/30/2025

	1M	2M	3M	6M	1Y	3Y
Beta	0.17	0.41	0.57	1.18	1.24	1.21
Up Beta	2.52	1.18	1.12	1.44	1.36	1.35
Down Beta	0.16	-0.09	0.07	1.10	1.20	1.23
Up Capture	-73%	-11%	-21%	49%	100%	154%
Bmk +ve Days	13	23	35	74	144	420
Stock +ve Days	11	23	32	65	131	410
Down Capture	42%	77%	148%	105%	116%	102%
Bmk -ve Days	8	19	29	52	107	330
Stock -ve Days	10	19	31	60	119	340

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date	9302025
Short Interest: Shares Quantity	8,224,603
Short Interest: % Change Since 9152025	43.9%
Average Daily Volume	2,513,600
Days-to-Cover Short Interest	3.27
Basic Shares Quantity	358,500,000
Short % of Basic Shares	2.3%

Returns Analyses

	Title
0	ISRG YTD Stock Return Of 6.7% Outperforms BDX by 30% and Underperforms BSX by -7.6%
1	Will You Be Comfortable Buying Intuitive Surgical Stock?
2	ISRG YTD Stock Return Of -41% Underperforms EW by -5.2% and Underperforms BSX by -35%
3	Intuitive Surgical Stock Return Comparison
4	[10/16/2021] Intuitive Surgical (ISRG) Stock Price Forecast: AI Forecasts ISRG Stock Price To Be Around $335 In A Month (Up 1.1%)
5	Intuitive Surgical Total Shareholder Return (TSR): 27.1% in 2023 and 7.4% 3-yr returns (above peer average)

Earnings Returns History

Expand for More

	Forward Returns
Earnings Date	1D Returns	5D Returns	21D Returns
7/22/2025	-1.8%	-2.8%	-6.0%
4/22/2025	1.9%	7.6%	14.3%
1/15/2025	7.7%	13.3%	9.7%
10/17/2024	10.0%	8.0%	11.4%
7/18/2024	9.3%	5.0%	15.1%
4/18/2024	-1.7%	0.1%	7.0%
1/9/2024	10.3%	8.6%	17.1%
10/19/2023	-2.4%	-5.1%	11.6%
...
SUMMARY STATS
# Positive	15	17	18
# Negative	9	7	6
Median Positive	7.0%	4.3%	9.1%
Median Negative	-2.4%	-5.5%	-10.4%
Max Positive	10.9%	22.8%	35.8%
Max Negative	-14.3%	-17.4%	-25.6%

	Forward Returns
7/22/2025	-1.8%	-2.8%	-6.0%
4/22/2025	1.9%	7.6%	14.3%
1/15/2025	7.7%	13.3%	9.7%
10/17/2024	10.0%	8.0%	11.4%
7/18/2024	9.3%	5.0%	15.1%
4/18/2024	-1.7%	0.1%	7.0%
1/9/2024	10.3%	8.6%	17.1%
10/19/2023	-2.4%	-5.1%	11.6%
7/20/2023	-3.2%	-6.9%	-17.8%
4/18/2023	10.9%	9.5%	14.5%
1/11/2023	-4.2%	-5.5%	-10.0%
10/18/2022	9.0%	22.8%	35.8%
7/21/2022	-5.7%	2.6%	0.0%
4/21/2022	-14.3%	-17.4%	-25.6%
1/12/2022	-1.5%	-10.5%	-10.8%
10/19/2021	1.0%	3.7%	7.5%
7/20/2021	-1.1%	2.1%	8.8%
4/20/2021	9.9%	6.2%	0.7%
1/13/2021	2.9%	1.3%	1.3%
10/15/2020	1.6%	-1.1%	1.7%
7/21/2020	3.5%	3.3%	5.1%
4/8/2020	4.2%	4.3%	9.4%
1/9/2020	2.2%	2.1%	-0.1%
10/17/2019	7.0%	3.5%	7.6%
SUMMARY STATS
# Positive	15	17	18
# Negative	9	7	6
Median Positive	7.0%	4.3%	9.1%
Median Negative	-2.4%	-5.5%	-10.4%
Max Positive	10.9%	22.8%	35.8%
Max Negative	-14.3%	-17.4%	-25.6%

SEC Filings

Expand for More

Report Date	Filing Date	Filing
6302025	7232025	10-Q 6/30/2025
3312025	4232025	10-Q 3/31/2025
12312024	1312025	10-K 12/31/2024
9302024	10182024	10-Q 9/30/2024
6302024	7192024	10-Q 6/30/2024
3312024	4192024	10-Q 3/31/2024
12312023	1312024	10-K 12/31/2023
9302023	10202023	10-Q 9/30/2023
6302023	7242023	10-Q 6/30/2023
3312023	4202023	10-Q 3/31/2023
12312022	2102023	10-K 12/31/2022
9302022	10212022	10-Q 9/30/2022
6302022	7222022	10-Q 6/30/2022
3312022	4222022	10-Q 3/31/2022
12312021	2032022	10-K 12/31/2021
9302021	10202021	10-Q 9/30/2021

Insider Activity

Expand for More

	Owner	Title	Filing Date	Action	Price	Shares	Transacted Value	Value of Held Shares	Form
0	Ladd Amy L		9042025	Sell	470.11	336	157,957	504,898	Form
1	Brosius Mark	SVP & Chief Mfg and Supply Cha	6062025	Sell	560.70	215	120,551	629,666	Form
2	Brosius Mark	SVP & Chief Mfg and Supply Cha	6042025	Sell	549.06	215	118,048	970,738	Form
3	Brosius Mark	SVP & Chief Mfg and Supply Cha	5162025	Sell	560.00	22	12,320	1,121,680	Form
4	Brosius Mark	SVP & Chief Mfg and Supply Cha	5142025	Sell	551.97	22	12,143	1,142,026	Form

Industry Resources

Health Care Resources

U.S. National Library of Medicine

Health Data Management

FDA Tracker

Health Care Equipment Resources

MedTech Dive

MassDevice

Fierce Medical Devices

Medical Device and Diagnostic Industry

MD+DI

External Quote Links

0	Y Finance	Barrons
1	TradingView	Morningstar
2	SeekingAlpha	ValueLine
3	Motley Fool	Robinhood
4	CNBC	Etrade
5	MarketWatch	Unusual Whales
6	YCharts	Perplexity Finance
7	FinViz

Prefer one of these to Trefis? Tell us why.

Intuitive Surgical (ISRG)

Market Price (10/15/2025): $437.37 | Market Cap: $156.8 BilSector: Health Care | Industry: Health Care Equipment

Intuitive Surgical (ISRG)

Market Price (10/15/2025): $437.37Market Cap: $156.8 BilSector: Health CareIndustry: Health Care Equipment

Investment Highlights

Market Valuation & Key Metrics

ISRG Stock

Price Returns Compared

Downturns Compared

How Low Can It Go?

Preserve Wealth

Asset Allocation

About Intuitive Surgical (ISRG)

Interactive Breakdown

Better Bets than Intuitive Surgical (ISRG)

Latest Trefis Analyses

Trade Ideas

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

1 Month Top Gainers

1 Month Top Losers

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Intuitive Surgical

Financials

Growth & Margins

Valuation

Returns

Comparison Analyses

FDIC Bank Data

Bank Capital

Bank Deposits

Bank Assets

Bank Loans

Financials

Segment Financials

Price Behavior

Short Interest

Returns Analyses

Earnings Returns History

SEC Filings

Insider Activity

Industry Resources

External Quote Links

Market Price (10/15/2025): $437.37 | Market Cap: $156.8 Bil
Sector: Health Care | Industry: Health Care Equipment

Market Price (10/15/2025): $437.37
Market Cap: $156.8 Bil
Sector: Health Care
Industry: Health Care Equipment